Fundraising Fox

TruDataRx

Norwich, US · Founded 2017 · Delaware corporation

TruDataRx applies comparative effectiveness research to help employer plan sponsors optimize pharmacy formulary coverage decisions based on clinical efficacy data rather than rebate incentives. The company combines peer-reviewed scientific research with proprietary analytics to reduce prescription drug spending while improving member outcomes.

Founders & leadership

DP
David PrintyNamed on SEC filing
CG
Catalina GorlainFounder

Board

GF
Gregg FairbrothersBoard director

Reported raises · per SEC filings

Form D private placements

$275K disclosed across 1 round · 2017

$275KraisedJun 2017 · 6 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • David PrintyExecutive Officer, Director
  • Catalina Elisabeth GorlaExecutive Officer, Director
  • Gregg FairbrothersDirector
Offering amount
$500K
Amount sold
$275K
Minimum investment
$10K
Proceeds to insiders
$85K
First sale
May 2017
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap

Companies competing with TruDataRx for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does TruDataRx do?
TruDataRx applies comparative effectiveness research to help employer plan sponsors optimize pharmacy formulary coverage decisions based on clinical efficacy data rather than rebate incentives. The company combines peer-reviewed scientific research with proprietary analytics to reduce prescription drug spending while improving member outcomes.
How much funding has TruDataRx raised?
TruDataRx has disclosed $275K raised across 1 round.
Where is TruDataRx headquartered?
TruDataRx is headquartered in Norwich, US.